|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.955 USD | +3.31% |
|
+6.29% | -19.47% |
| Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
| Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
The
The biotechnology company posted revenue of
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
Copyright by Automated Insights, Inc. All rights reserved., source
| 1st Jan change | Capi. | |
|---|---|---|
| -19.47% | 1.81B | |
| -1.42% | 105B | |
| +3.35% | 97.5B | |
| +1.86% | 22.19B | |
| -16.60% | 21.33B | |
| -8.49% | 18.68B | |
| -42.33% | 16.6B | |
| -20.63% | 14.52B | |
| +5.37% | 14.09B | |
| +28.72% | 10.99B |
RECURSION PHARMACEUTICALS, INC. 
